Central descending serotonergic pathway (CDSP)

The central descending serotonergic pathway is a major component of the endogenous pain modulation system, originating in the medullary raphe nuclei and projecting to the spinal cord dorsal horn [StatPearls: NBK535403]. It serves as a critical regulator of sensory input, where the release of serotonin (5-HT) can either inhibit or facilitate nociceptive transmission depending on the specific receptor subtypes engaged, such as the inhibitory 5-HT1A or excitatory 5-HT2 and 5-HT3 receptors [PubMed: 22330705]. In healthy individuals, this pathway primarily provides descending inhibition to prevent the over-sensitization of spinal neurons to peripheral stimuli. However, dysfunction or a shift toward descending facilitation is a hallmark of chronic pain conditions like fibromyalgia and neuropathic pain [PubMed: 21448033]. Pharmacological interventions, such as SNRIs and tricyclic antidepressants, aim to enhance the inhibitory capacity of this pathway by increasing serotonin availability at spinal synapses [PubMed: 24634430]. Beyond pain, the pathway also influences motor neuron excitability and autonomic functions, making it a complex but vital system for central nervous system homeostasis.

Other names

Descending serotonergic systemBulbospinal serotonergic pathwayRaphe-spinal pathwayDescending inhibitory serotonergic projection

Drugs targeting this system primarily act by inhibiting the reuptake of serotonin (and often norepinephrine) at the synaptic cleft within the spinal cord dorsal horn, thereby increasing the activation of inhibitory serotonergic receptors on nociceptive neurons to suppress pain transmission [PubMed: 24634430].